At Glaukos, their focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.

Medical Devices

Glaukos

Thomas W. Burns

Steve Pommerenk

Sean Hutchings

Niven Smith

Tim Homer

Thomas Grosskopf

David Applegate

Brian Collins

Andrew Geddes

Terence Koritz

Steve Henderson

Charles Kamen

Mark Rhein

Paula B.

Cheyenne Arrowsling

Brandy McCracken

John McLean

Melissa Chaves

Malaty Kittikhoun

Hugh Ross

Cristina Sanchez Gonzalez

Cristina Minella

Robert Sanchez

Chinmay Maheshwari

Mike Neilon

Alex R. Thurman

Matt Young

Tomas Navratil

David S. Haffner

Gabriella Szekely

Joseph E. Gilliam

Jane E. Rady

Diane W. Biagianti

Michele M. Allegretto

Jay L. Katz

The Clinical Research and Development team at Glaukos is responsible for designing, conducting, and overseeing clinical trials aimed at evaluating the safety and efficacy of innovative ophthalmic therapies. They collaborate with various stakeholders to ensure compliance with regulatory requirements, manage data collection, and analyze results to inform product development strategies, ultimately advancing new treatment options for patients with eye diseases.

Clinical Research and Development

Sales and Market Access

Leadership Team

Quality Assurance and Compliance

Clinical Research and Development

About

Team members

Other teams at Glaukos

Sales and Market Access

Leadership Team

Quality Assurance and Compliance